Hormonal Regulation of Circulating C-Reactive Protein in Men
Open Access
- 1 May 2005
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 51 (5), 911-913
- https://doi.org/10.1373/clinchem.2004.046169
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Estrogens, lipoproteins, and cardiovascular risk factors: an update following the randomized placebo-controlled trials of hormone-replacement therapyCurrent Opinion in Lipidology, 2004
- The Effect of Different Doses of Micronized 17ss-Estradiol on C-Reactive Protein, Interleukin-6, and Lipids in Older WomenThe Journals of Gerontology: Series A, 2004
- The Role of Estrogen and Estrogen-Related Drugs in Cardiovascular DiseasesCurrent Drug Metabolism, 2003
- New Markers for Cardiovascular Disease Risk in Women: Impact of Endogenous Estrogen Status and Exogenous Postmenopausal Hormone TherapyJournal of Clinical Endocrinology & Metabolism, 2003
- Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndromeJournal of the American College of Cardiology, 2003
- Human C-reactive protein: expression, structure, and functionMolecular Immunology, 2001
- Prospective Study of C-Reactive Protein and the Risk of Future Cardiovascular Events Among Apparently Healthy WomenCirculation, 1998
- Testosterone and IL-6 Requirements for Human C-Reactive Protein Gene Expression in Transgenic MiceThe Journal of Immunology, 1998
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997
- Orchidectomy versus oestrogen for prostatic cancer: cardiovascular effects.BMJ, 1986